Thymopentin
TP-5 / RKDVY
- Peptide length
- 5 amino acids
Pentapeptide
Published sequence
RKDVYAmino acids are shown with one-letter codes. Check the source for the exact molecular form.
Open the sources to check how the studies were done and what they can support.
A thymopoietin-derived pentapeptide studied in immune research and as a starting point for stabilized analogs.
- Family
- Thymopoietin-derived peptide
- Research target
- Immune modulation
- Molecular form
- Pentapeptide
What to know about the research
The linked chemistry study tested modified analogs and serum stability. It is not a clinical efficacy trial of thymopentin.
Check the exact compound
The parent sequence is Arg-Lys-Asp-Val-Tyr. Bond replacements and stabilized analogs create distinct molecules.
What supports this entry?
The reference list is available. A statement-by-statement source check has not been completed for this entry.
These are selected references, not a complete review of the literature. Source checks were assisted by AI and have not received independent expert review.
Research stage, study quality and regulatory status answer different questions. A study card does not establish treatment benefit or approval.
No study details have been extracted for this exact entry yet. This does not mean that no studies exist. Open the references and check the exact material.
How we prepare and correct these entries